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Background: Breast cancer is among the commonest cancers affecting women in Tanzania. Most of 
them seek hospital treatment when the disease has reached an advanced stage. Hence widely 
available modalities like ultrasound (LUS) and chest radiograph (CXR) can be used to establish 
metastasis in newly diagnosed patients. The main objective of this study was to determine the role of 
abdominal ultrasound and chest radiography in detection of liver and lung metastasis in newly 
diagnosed breast cancer patients. 
Methods: This was a descriptive cross sectional study in which 103 new breast cancer patients 
attending Ocean Road Cancer Institute (ORCI) were recruited consecutively. All participants were 
investigated for liver and lung metastases using abdominal ultrasound and chest x-ray respectively. 
Standardized questionnaires were used to obtain socio-demographic and to document examination 
findings.  
Results: Participants were aged between 26 – 77 years, with a mean of 48±11.22. The prevalence of 
metastasis to the liver and lungs were 18.4% and 20.4% respectively. Majority of patients with breast 
cancer had locally advanced breast cancer disease that is either TNM stage three (59.2%) or four 
(32%) disease upon arrival to ORCI.  
Conclusion: This study has demonstrated a high detection rate of LUS and CXR for liver and lung 




Breast cancer is a disease with high prevalence in females worldwide, contributing to a substantial 
public health burden. Although breast cancer was once known to affect highly affluent communities, it 
has been realized that disadvantaged communities now are facing the heaviest disease burden. It is 
estimated that more than 1.3 million cases of breast cancer are diagnosed each year. This disease 
accounts for 10.9% of all cancers and 22.8% of all cancers in women worldwide1. In USA one out of 
eight women will be diagnosed of breast cancer in her lifetime. Breast cancer is the leading cause of 
mortality and morbidity in Asia and Latin America2.  
 
Cancer of the breast is among the commonest cancer affecting women in Tanzania. It is estimated that 
approximately 1307 women with breast cancer register in different hospitals in Tanzania each year3. 
Majority of women who are diagnosed with breast cancer seek hospital treatment when the disease has 
reached an advanced stage, at which point metastasis to the lungs or liver are most likely4.   
 
Lack of knowledge about breast cancer among the general population and lack of regular systematic 
breast cancer screening program are some of the factors for late presentation at Ocean Road Cancer 
Institute (ORCI)5. A study done in 1996 at Muhimbili National Hospital (MNH) found that more than 
90% of breast cancer patients had stage III or more disease, with high probability of a distant metastasis 
to the lungs or liver4.  Liver metastasis is a primary clinically significant contributor to mortality 
associated with breast cancer, and present in about two-thirds of women with metastatic disease. At the 
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same time sixty to seventy percent of patients who die of breast cancer eventually have metastasis in 
their lungs6. 
 
In Tanzania, where resources are limited, widely available modalities like ultrasound (LUS) and chest 
radiograph (CXR) can be used to establish early overt metastasis in breast cancer patients.They are 
reliable, fast, cheap and easy modalities in detecting liver and lung metastasis and for predicting 
prognosis in breast cancer patients. However, in case of microscopic liver metastasis LUS maybe 
normal hence complementary examinations like, computed tomography (CT scan), Magnetic 
Resonance Imaging (MRI) and Positron emission tomography (PET) should be done where resources 
are available7. On the other hand, CXR is very beneficial since it can upgrade patient who had stage I or 
II to stage IV, and hence determine the appropriate treatment plan8. In situations where CXR 
interpretations maybe inconclusive advanced radiological investigations like Computed tomography 
(CT) scan may be needed.  
 
The aim of this study was therefore to show that in a low resource country like Tanzania, LUS and 
CXR are very beneficial in staging, treatment planning, follow up and prognosis determination of breast 
cancer patients. 
Patients and Methods 
This was a six months hospital based descriptive cross sectional study carried out between June and 
Dec 2010 at Ocean Road Cancer Institute (ORCI) in Dar es Salam Tanzania. ORCI is the only 
specialized centre for cancer treatment in Tanzania, handling cancer patients from all over the country 
of 45million people. Its treatment modalities range from chemotherapy, radiotherapy by external beam, 
hormonal therapy and to a lesser extent immunotherapy. Patients are either referred for neo/adjuvant 
therapy or palliative options using the above and the cancer surgery is done by the referring hospitals. 
The centre receives about 4,000 new cancer cases every year, two thirds of whom are women. Breast 
cancer cases comprise 10%- 14% of all new cancer cases seen at the institute. The confirmation of 
diagnosis was done by the referring hospitals, including TNM staging for those that have undergone a 
mastectomy. All patients come to ORCI with results from pathology laboratories either with a 
Histopathology (HP) or histocytology (HC) number.  
 
Male patients were excluded from this study along with those who did not have tissue reports 
confirming the diagnosis. A total of 103 patients were therefore recruited into this study. Each 
underwent an abdominal ultra sound and chest x-ray evaluation to check for evidence of metastasis. 
Structured questionnaire was used to collect information regarding patient’s socio-demographic details, 
abdominal ultrasound and chest x-ray findings. Abdominal ultrasound was done using a PHILIPS HD 
4000 system with broadband curve-linear transducers of 2MHz to 5MHz range (Best, Eindhovern, The 
Netherlands) which is in a routine use at the Radiology department. Metastasis was defined as any 
lesion in the liver which its echotexture was heterogeneous, hypoechoic, or isoechoic be it solitary or 
multiple with irregular margins and had a size of more than 1cm.   
 
A high KV technique chest radiograph postero-anterior (PA) view was obtained by a Radiographer 
using PHILIPS HD 30 system (Best, Eindhoven, The Netherlands). All chest x-rays were reported by 
the Researcher then re-reported by a qualified Radiologist. Lung metastasis was defined as presence of 
solitary or multiple lung nodules with irregular margins, reticulo-nodulations, or presence of pleural 
effusion  
 
The limitation to this study was that neither tissue confirmation was performed to confirm that the 
lesions seen were indeed metastasis from the breast nor a follow up to document on the response to 
therapy offered. Ethical clearance was sought from ethical clearance board (IRB) of the Muhimbili 
University of Health and Allied Sciences (MUHAS) which is also an ethical clearing body for ORCI. 
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Permission to conduct the study was sought from Ocean Road Cancer Institute to use the subjects for 
the Study. Data analysis was done using Statistical Packages for Social Science (SPSS) version 15.   
Results 
A total of 103 women with breast cancer were recruited into the study, aged between 26 – 77, with 64 
(61.5%)of them being 45 years and with a mean of 48±11.22. Fifty (48.5%) of the patients had primary 
level of education. The majority (64%) of the patients were married. Fifty six (53.8%) had no formal 
source of income(Table 1). Overall, the majority of newly diagnosed patients had locally advanced 
breast cancer with either TNM stage three 61(59.2%) or four 33(32.0%) disease, very few had stage II 
and none had stage I. There is a trend of decreasing in stage 3 with increasing age, while there is an 
increasing trend of stage 4 with increasing age (Figure 1). A total of 38.8% (40/103) of the breast 
cancer patients had LUS and Chest X-ray detectable metastasis. Those aged 45 years and above had the 
highest prevalence of metastasis at 44.3%, the least being in those between 25-34 years of age. Lung 
metastasis was most commonly observed at 20.4% (21/103)        (Table 2).  
 
Table 1.Demographic and baseline characteristics of study population (N=103) 
 
Characteristics Number  Percentage 
Age in Years   
25-34 10  9.6% 
35-44 29  27.9% 
45 and above 




Marital status   
Single 10  9.7% 
Married 66  64.0% 
Divorced 27  26.2% 
Education level   
No formal education 25  24.3% 
Primary education 50  48.5% 
Post primary education 28  27.2% 
Occupation   
Formal and informal occupation 47  46.2% 
No occupation 56  53.8% 
 
 
Figure 1.Distribution of Study Sample by Age and TNM Stage 
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Table 2.Prevalence of Liver and Lung Metastasis According to Age   ( n = 103) 
Age (Yrs) Liver Lung Total 
25-34 (10) 2(20%) 1(10%) 30% 
35-44 (24) 4(13.8%) 6(20.7%) 34.5% 
>45 (61) 13 (21.3%) 14 (23%) 44.3% 




Lung and liver metastasis contributes to morbidity and mortality in women with breast cancer disease 
making both clinical and radiological staging to be of paramount importance in patient management 
plan. The purpose of staging in resource constrained settings is to rule out overt metastasis, with 
resultant treatment and prognostic implications. In this study, the findings of breast cancer TNM stages 
do not differ with studies done in other parts of Africa whereby more than 90% had locally advanced 
breast cancer which was either stage III or IV disease at the time of diagnosis and none presented with a 
stage one disease4. These findings have remained the same in spite of more recent campaigns to create 
awareness of breast cancer among women conducted by Medical Women Association of Tanzania 
(MEWATA) in almost the whole country5.   
 
The reasons for these late presentations might be multifactorial but were beyond the scope of this study. 
More than half of the studied women had no any kind of work that generated income. This lack of 
economic independence has been shown to limit access to information and access to early care seeking 
behaviour. This is also aggravated by a lack of formal education which might lead to holding of 
traditional beliefs hence seeking other help outside the formal health care setting before finally 
presenting with an advanced disease9. But study by MEWATA had sited that a lack mammography at 
primary health care facilities, poverty, difficult referral system, myths and misconceptions were among 
the factors accounting for advanced disease at presentation5.  
In South Africa a similar study was done about TNM stage of newly diagnosed breast cancer patients 
and compared blacks and white patients. Findings were similar to what was seen in this study whereby 
stages III and IV of breast cancer were the most prevalent in black women (77.7%) compared to white 
women (30.7%). The reasons given were that for blacks having Locally Advanced Breast Cancer 
(LABC) at the time of diagnosis was interpreted as a reflection of conflicts, particularly in social 
relationships. Many patients with cancer believed that a special witchcraft caused their cancer; hence 
the first priority was to reverse the sorcery by seeking help from tradition healers before presenting to 
hospital10.  
 
Moreover locally advanced breast cancer is the most common form of presentation for breast cancer 
patients in countries of limited resources, and, along with stage IV disease, it represents up to about 
80% of new patients at presentation in Arabic and African communities11. This means that our patients 
have poor prognosis in comparison to breast cancer patients in developed world who are usually picked 
up with an early breast cancer disease stage I/II. Furthermore death occurring due to breast cancer 
shows significant differences among stages: only 5% to 12% of Stage I/II patients die in the first 10 
years after diagnosis, compared with over 60% of Stage III patients and over 90% of Stage IV 
patients12. In this study the detection rate of lung and liver metastasis in newly diagnosed breast cancer 
was 20.4% and 18.4% respectively. This is high compared to what was seen by other researchers 
elsewhere. 
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In Toronto Canada they found out that the prevalence of metastatic disease in locally advanced breast 
cancer (LABC) was 13.2%. This supports the continued need for full routine staging tests for patients 
with LABC as compared with those women with earlier stage disease. The Canadian study subjected all 
women who had LUS and CXR negative to more complex studies like computed tomography, magnetic 
resonance imaging (MRI) and/or positron emission tomography (PET), where an additional 2.8% 
metastasis was found13. In our setting, though CT scanning and MRI are available, they are largely 
expensive and will delay timely intervention hence was not considered. This implies that there was a 
possibility that we missed about 2.8% distant metastasis but still our breast cancer metastasis detection 
rate was still very high. 
 
In the Netherlands in 2002, wherein 399 breast cancer women underwent LUS and CXR, the 
prevalence of liver and lung metastasis were 1.5% and 1% respectively14. This was similar to an Italian 
study finding, thus suggesting that these investigations are largely unnecessary in early breast cancer 
patients15. But the two studies only involved early breast cancer patients hence their conclusions might 
not have sound implications in this series where the detection rate has been demonstrated to be high. 
 
The ability to accurately stage patients has many benefits. Firstly, clinicians will be better able to advise 
patients on their prognosis. Secondly, appropriate palliative measures can be introduced at an earlier 
opportunity. Finally, clinicians will be able to better individualize treatment to their patients. 
Conversely, in those who present with metastatic disease, a more balanced, quality-of-life oriented 
approach can be utilized. It is, however, considered beneficial for the accurate staging of disease to be 
known when decisions regarding adjuvant systemic therapy are made13. To aide this, our study has 
provided evidence that abdominal ultra sound and chest x-ray should be performed routinely on every 
patient presenting with LABC who are majority at the ORCI.  
 
Conclusion 
This study has demonstrated a high detection rate of LUS and CXR for liver and lung metastasis in 
patients with locally advanced breast cancer. 
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